Ongoing Trials Studying Immunotherapy as a First-Line Treatment in Head and Neck Cancer

October 3, 2016
Barbara Ann Burtness, MD

Barbara Ann Burtness, MD, professor of medicine, Clinical Research Program Leader, Head and Neck Cancers Program and Co-Director, Developmental Therapeutics Research Program at Yale Cancer Center, discusses the ongoing trials looking at immunotherapy as a first-line treatment in head and neck cancer.